Table 3. 1H NMR of urine metabolites.
Metabolite number | Name of metabolite | δ (ppm) | Athlete Fold Change (±SD) | Control Fold Change (±SD) | p-value |
M1 | 2-Hydroxybutyrate | 0.90 | 1.28±0.23 | 1.48±0.65 | 0.44 |
M2 | 2-Hydroxyisovalerate | 3.85 | 1.12±0.39 | 1.44±0.12 | 0.046* |
M3 | α-Ketoglutarate | 2.45 | 0.98±0.29 | 1.03±0.41 | 0.78 |
M4 | 2-Oxoisocaproate | 0.94 | 1.19±0.12 | 1.24±0.12 | 0.40 |
M5 | 2-Oxoisovalerate | 1.12 | 1.28±0.39 | 1.31±0.59 | 0.94 |
M6 | 3-Hydroxybutyrate | 1.20 | 0.82±0.21 | 0.77±0.19 | 0.64 |
M7 | 3-Hydroxyisobutyrate | 1.07, 3.68‡ | 1.33±0.24 | 1.38±0.35 | 0.78 |
M8 | 3-Methyl-2-oxovalerate | 1.10, 2.94‡ | 1.11±0.19 | 1.15±0.35 | 0.82 |
M9 | Acetoacetate | 2.24 | 0.91±0.12 | 1.05±0.26 | 0.23 |
M10 | Alanine | 1.49 | 1.16±0.29 | 1.12±0.39 | 0.83 |
M11 | Citrate | 2.55 | 0.63±0.15 | 0.66±0.19 | 0.70 |
M12 | Creatinine | 3.05 | 1.03±0.21 | 1.14±0.22 | 0.34 |
M13 | Glycine | 3.57 | 0.84±0.09 | 0.93±0.04 | 0.019* |
M14 | Formate | 8.46 | 0.96±0.05 | 0.84±0.14 | 0.043* |
M15 | Lactate | 1.33 | 4.34±1.21 | 7.16±6.61 | 0.10 |
M16 | Malonate | 3.11 | 1.13±0.35 | 1.78±0.41 | 0.004* |
M17 | Phenylalanine | 3.98, 7.36‡ | 0.91±0.09 | 0.95±0.11 | 0.49 |
M18 | Pyruvate | 2.35 | 1.70±0.22 | 1.68±0.43 | 0.92 |
M19 | Succinate | 2.53 | 0.89±0.12 | 0.81±0.19 | 0.12 |
M20 | Hippurate | 7.56 | 0.91±0.56 | 0.96±0.63 | 0.86 |
M21 | Trimethylamine N-oxide | 3.25 | 0.88±0.22 | 0.83±0.31 | 0.70 |
M22 | Acetate | 1.93 | 1.32±0.14 | 4.21±0.12 | 0.0001* |
M23 | Hypoxanthine | 8.19 | 4.34±1.12 | 2.91±0.98 | 0.016* |
M24 | Tryptophan | 4.06, 7.32‡ | 0.83±0.05 | 0.94±0.08 | 0.004* |
M25 | Inosine | 4.28‡, 6.10 | 1.39±0.71 | 1.29±0.84 | 0.81 |
M26 | Glucuronate† | 3.73 | - | - | - |
M27 | 3-Hydroxyisovalerate† | 1.26 | - | - | - |
M28 | Valine | 0.99, 3.60 | 0.98±0.07 | 1.01±0.12 | 0.55 |
M29 | Fumarate | 6.51 | 2.16±0.45 | 1.53±0.39 | 0.009* |
M30 | Malate♮ | 4.29 | - | - | - |
M31 | Histidine♭ | 7.09 | - | - | - |
M32 | Leucine♮ | 0.95, 1.70 | - | - | - |
H NMR identified urine metabolites and relative changes in concentration reported as fold change for athlete and control groups after exercise.
‡Signal not used for concentration calculation.
†Peak areas were unreported due to peak overlap.
♮Metabolite not detected.
*Significant difference between gr°ups.
♭Histidine concentrations were not calculated due to dynamic nature of His resonances.